Initiator Pharma A/S's market cap is currently kr222.47M. The company's EPS TTM is kr-0.101; its P/E ratio is ―; Initiator Pharma A/S is scheduled to report earnings on August 22, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
